Literature DB >> 30664273

Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome.

John-Paul Berauer1, Anya I Mezina1, David T Okou1, Aniko Sabo2, Donna M Muzny2, Richard A Gibbs2, Madhuri R Hegde3, Pankaj Chopra3, David J Cutler3, David H Perlmutter4, Laura N Bull5, Richard J Thompson6, Kathleen M Loomes7, Nancy B Spinner8, Ramakrishnan Rajagopalan8,9, Stephen L Guthery10, Barry Moore11, Mark Yandell11, Sanjiv Harpavat12, John C Magee13, Binita M Kamath14, Jean P Molleston15, Jorge A Bezerra16, Karen F Murray17, Estella M Alonso18, Philip Rosenthal19, Robert H Squires20, Kasper S Wang21, Milton J Finegold22, Pierre Russo23, Averell H Sherker24, Ronald J Sokol25, Saul J Karpen1.   

Abstract

Biliary atresia (BA) is the most common cause of end-stage liver disease in children and the primary indication for pediatric liver transplantation, yet underlying etiologies remain unknown. Approximately 10% of infants affected by BA exhibit various laterality defects (heterotaxy) including splenic abnormalities and complex cardiac malformations-a distinctive subgroup commonly referred to as the biliary atresia splenic malformation (BASM) syndrome. We hypothesized that genetic factors linking laterality features with the etiopathogenesis of BA in BASM patients could be identified through whole-exome sequencing (WES) of an affected cohort. DNA specimens from 67 BASM subjects, including 58 patient-parent trios, from the National Institute of Diabetes and Digestive and Kidney Diseases-supported Childhood Liver Disease Research Network (ChiLDReN) underwent WES. Candidate gene variants derived from a prespecified set of 2,016 genes associated with ciliary dysgenesis and/or dysfunction or cholestasis were prioritized according to pathogenicity, population frequency, and mode of inheritance. Five BASM subjects harbored rare and potentially deleterious biallelic variants in polycystic kidney disease 1 like 1 (PKD1L1), a gene associated with ciliary calcium signaling and embryonic laterality determination in fish, mice, and humans. Heterozygous PKD1L1 variants were found in 3 additional subjects. Immunohistochemical analysis of liver from the one BASM subject available revealed decreased PKD1L1 expression in bile duct epithelium when compared to normal livers and livers affected by other noncholestatic diseases.
Conclusion: WES identified biallelic and heterozygous PKD1L1 variants of interest in 8 BASM subjects from the ChiLDReN data set; the dual roles for PKD1L1 in laterality determination and ciliary function suggest that PKD1L1 is a biologically plausible, cholangiocyte-expressed candidate gene for the BASM syndrome.
© 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2019        PMID: 30664273      PMCID: PMC6642859          DOI: 10.1002/hep.30515

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  48 in total

Review 1.  Piecing together a ciliome.

Authors:  Peter N Inglis; Keith A Boroevich; Michel R Leroux
Journal:  Trends Genet       Date:  2006-07-24       Impact factor: 11.639

2.  The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study.

Authors:  Mark Davenport; Sarah A Tizzard; James Underhill; Giorgina Mieli-Vergani; Bernard Portmann; Nedim Hadzić
Journal:  J Pediatr       Date:  2006-09       Impact factor: 4.406

3.  The sequence, expression, and chromosomal localization of a novel polycystic kidney disease 1-like gene, PKD1L1, in human.

Authors:  Takeshi Yuasa; Bhuvarahamurthy Venugopal; Stanislawa Weremowicz; Cynthia C Morton; Lei Guo; Jing Zhou
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

4.  Implication of early-onset biliary atresia and extrahepatic congenital anomalies.

Authors:  Ming-Chun Yang; Mei-Hwei Chang; Shuenn-Nan Chiu; Shinn-Forng Peng; Jia-Feng Wu; Yen-Hsuan Ni; Huey-Ling Chen
Journal:  Pediatr Int       Date:  2010-08       Impact factor: 1.524

5.  Situs inversus in Dpcd/Poll-/-, Nme7-/- , and Pkd1l1-/- mice.

Authors:  P Vogel; R Read; G M Hansen; L C Freay; B P Zambrowicz; A T Sands
Journal:  Vet Pathol       Date:  2010-01       Impact factor: 2.221

6.  Cildb: a knowledgebase for centrosomes and cilia.

Authors:  Olivier Arnaiz; Agata Malinowska; Catherine Klotz; Linda Sperling; Michal Dadlez; France Koll; Jean Cohen
Journal:  Database (Oxford)       Date:  2009-12-07       Impact factor: 3.451

7.  CFC1 gene involvement in biliary atresia with polysplenia syndrome.

Authors:  Anne Davit-Spraul; Christiane Baussan; Bogdan Hermeziu; Olivier Bernard; Emmanuel Jacquemin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-01       Impact factor: 2.839

Review 8.  Cholangiocyte primary cilia in liver health and disease.

Authors:  Anatoliy I Masyuk; Tatyana V Masyuk; Nicholas F LaRusso
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

Review 9.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

Review 10.  Familial biliary atresia in three siblings including twins.

Authors:  B M Smith; J M Laberge; R Schreiber; A M Weber; H Blanchard
Journal:  J Pediatr Surg       Date:  1991-11       Impact factor: 2.545

View more
  13 in total

1.  Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia.

Authors:  Xiao Zhao; Kristin Lorent; Diana Escobar-Zarate; Ramakrishnan Rajagopalan; Kathleen M Loomes; Kevin Gillespie; Clementina Mesaros; Michelle A Estrada; Ian A Blair; Jeffrey D Winkler; Nancy B Spinner; Marcella Devoto; Michael Pack
Journal:  Gastroenterology       Date:  2020-06-04       Impact factor: 22.682

2.  Biliary Atresia as a Disease Starting In Utero: Implications for Treatment, Diagnosis, and Pathogenesis.

Authors:  Krupa R Mysore; Benjamin L Shneider; Sanjiv Harpavat
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-10       Impact factor: 2.839

3.  Paediatric cholestatic liver disorders for the adult gastroenterologist: a practical guide.

Authors:  Claire Kelly; Jeremy Shanika Nayagam; Stamatina Vogli; Marianne Samyn; Deepak Joshi
Journal:  Frontline Gastroenterol       Date:  2020-08-03

Review 4.  Biliary Atresia in Children: Update on Disease Mechanism, Therapies, and Patient Outcomes.

Authors:  Swati Antala; Sarah A Taylor
Journal:  Clin Liver Dis       Date:  2022-06-25       Impact factor: 6.265

Review 5.  Biliary atresia and congenital disorders of the extrahepatic bile ducts.

Authors:  Ali Islek; Gokhan Tumgor
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-07-05

Review 6.  Genetic Factors and Their Role in the Pathogenesis of Biliary Atresia.

Authors:  Li-Na Wu; Zhi-Jun Zhu; Li-Ying Sun
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

7.  Portal plate bile duct diameter in biliary atresia is associated with long-term outcome.

Authors:  Michael Shpoliansky; Ana Tobar; Yael Mozer-Glassberg; Michal Rosenfeld Bar-Lev; Raanan Shamir; Michal Shafir; Michael Gurevich; Orith Waisbourd-Zinman
Journal:  Pediatr Surg Int       Date:  2022-03-23       Impact factor: 1.827

8.  TGF-β Signaling Plays a Pivotal Role During Developmental Biliary Atresia in Sea Lamprey (Petromyzon marinus).

Authors:  Yu-Wen Chung-Davidson; Jianfeng Ren; Chu-Yin Yeh; Ugo Bussy; Belinda Huerta; Peter Joseph Davidson; Steven Whyard; Weiming Li
Journal:  Hepatol Commun       Date:  2019-12-24

9.  Novel findings from family-based exome sequencing for children with biliary atresia.

Authors:  Kien Trung Tran; Vinh Sy Le; Lan Thi Mai Dao; Huyen Khanh Nguyen; Anh Kieu Mai; Ha Thi Nguyen; Minh Duy Ngo; Quynh Anh Tran; Liem Thanh Nguyen
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

Review 10.  Biliary Atresia: Clinical Phenotypes and Aetiological Heterogeneity.

Authors:  Mark Davenport; Ancuta Muntean; Nedim Hadzic
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.